ANIP Q3 Deep Dive: Rare Disease Momentum and Generics Expansion Drive Upgraded Outlook [Yahoo! Finance]
ANI Pharmaceuticals, Inc. (ANIP)
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
anipharmaceuticals.com/investors_corporate_profile.php
Company Research
Source: Yahoo! Finance
The company's full-year revenue guidance of $863.5 million at the midpoint came in 1.8% above analysts' estimates. Its non-GAAP profit of $2.04 per share was 15.2% above analysts' consensus estimates. Is now the time to buy ANIP? Find out in our full research report (it's free for active Edge members). ANI Pharmaceuticals (ANIP) Q3 CY2025 Highlights: Revenue: $227.8 million vs analyst estimates of $214.1 million (53.6% year-on-year growth, 6.4% beat) Adjusted EPS: $2.04 vs analyst estimates of $1.77 (15.2% beat) Adjusted EBITDA: $59.6 million vs analyst estimates of $55.24 million (26.2% margin, 7.9% beat) The company lifted its revenue guidance for the full year to $863.5 million at the midpoint from $830.5 million, a 4% increase Management raised its full-year Adjusted EPS guidance to $7.51 at the midpoint, a 4.7% increase EBITDA guidance for the full year is $224.5 million at the midpoint, above analyst estimates of $221.9 million Operating Margin: 15.9%, up from
Show less
Read more
Impact Snapshot
Event Time:
ANIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIP alerts
High impacting ANI Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ANIP
News
- ANI Pharmaceuticals Announces Formation of “FutureVision Advisory Council” to Help Strategically Guide Ophthalmology and Retina FranchiseGlobeNewswire
- ANI Pharmaceuticals Announces Board TransitionGlobeNewswire
- Does Recent Pipeline News Signal a New Opportunity for ANI Pharmaceuticals Stock in 2025? [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals to Present at the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals to Present at the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswire
ANIP
Earnings
- 11/7/25 - Beat
ANIP
Sec Filings
- 12/1/25 - Form 8-K
- 11/17/25 - Form 4
- 11/14/25 - Form 4
- ANIP's page on the SEC website